-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: keymaster@town.hall.org
Originator-Key-Asymmetric:
 MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq
 pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ==
MIC-Info: RSA-MD5,RSA,
 iTBwxx3SQ9M7qb6Vu0wu20i3Z6l53NLDwulweRMRdcESZyHeOQGPqaeyfvU1wClT
 +M0O4lpU2/+UVg3OK8bGZQ==

<IMS-DOCUMENT>0000914233-95-000013.txt : 19950516
<IMS-HEADER>0000914233-95-000013.hdr.sgml : 19950516
ACCESSION NUMBER:		0000914233-95-000013
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	19950331
FILED AS OF DATE:		19950515
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11178
		FILM NUMBER:		95539682

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</IMS-HEADER>
<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<DESCRIPTION>AMENDMENT
<TEXT>
                   
 
 


<PAGE> 
                     SECURITIES AND EXCHANGE COMMISSION 
                           Washington, D.C.  20549 
 
                                    FORM 10-Q/A
                                 (Amendment no. 1) 
 
                  Quarterly Report under Section 13 or 15(d) of 
                     The Securities Exchange Act of 1934 
 
 
For quarter ended:  March 31, 1995   Commission File No.  0-11178 
 
                        UTAH MEDICAL PRODUCTS, INC. 
           (Exact name of Registrant as specified in its charter) 
 
         UTAH                                       87-0342734 
 (State or other jurisdiction                       IRS Employer 
incorporation or organization)                 Identification No. 
 
 
                             7043 South 300 West 
                             Midvale Utah 84047 
                   (Address of principal executive offices) 
 
 
Registrant's telephone number:(801) 566-1200 
 
 
 
Indicate by check mark whether the registrant (1) has filed all  
reports required to be filed by Sections 13 or 15(d) of the  
Securities Exchange Act of 1934 during the preceding 12 months  
(or for such shorter period that the registrant was required to  
file such reports); and (2) has been subject to such filing  
requirements for the past 90 days.  Yes (X)  No ( ) 
 
The number of shares outstanding of the registrant's common stock as  
of May 12, 1995:  9,785,135 
 
<PAGE> 
SIGNATURES 
 
          Pursuant to the requirements of the Securities Exchanges Act  
of 1934, the registrant has duly caused this amendment to be signed on  
its behalf by the undersigned thereunto duly authorized. 
 
 
                              UTAH MEDICAL PRODUCTS, INC. 
                              REGISTRANT 
 
 
 
 
 
Date:May 15, 1995             By:/s/Kevin L. Cornwell                     
                              Kevin L. Cornwell 
                              President and CEO 
 
 
 
Date:May 15, 1995             By:/s/Kevin L. Cornwell                 
                              Kevin L. Cornwell 
                              Secretary and CFO 
</TEXT> 
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-27
<SEQUENCE>2
<DESCRIPTION>FINANCIAL DATA SCHEDULES
<TEXT>

<TABLE> <S> <C>
 
<ARTICLE>                   5 
        
<S>                                     <C>        
<FISCAL-YEAR-END>                        DEC-31-1995 
<PERIOD-START>                           JAN-01-1995 
<PERIOD-END>                             MAR-31-1995 
<PERIOD-TYPE>                            3-MOS 
<CASH>                                   4,187,291 
<SECURITIES>                             5,148,636 
<RECEIVABLES>                            5,485,792 
<ALLOWANCES>                             (83,283) 
<INVENTORY>                              3,906,877 
<CURRENT-ASSETS>                         19,595,691 
<PP&E>                                   13,359,455 
<DEPRECIATION>                           (5,151,191) 
<TOTAL-ASSETS>                           28,671,867 
<CURRENT-LIABILITIES>                    3,499,999 
<BONDS>                                  0 
<COMMON>                                 99,193 
<PREFERRED-MANDATORY>                    0 
<PREFERRED>                              0 
<OTHER-SE>                               24,470,308 
<TOTAL-LIABILITY-AND-EQUITY>             28,671,867 
<SALES>                                  9,754,041 
<TOTAL-REVENUES>                         9,754,041 
<CGS>                                    5,382,678 
<TOTAL-COSTS>                            1,840,215 
<OTHER-EXPENSES>                         (161,275) 
<LOSS-PROVISION>                         0 
<INTEREST-EXPENSE>                       (108,371) 
<INCOME-PRETAX>                          2,800,794 
<INCOME-TAX>                             980,277 
<INCOME-CONTINUING>                      1,820,517 
<DISCONTINUED>                           0 
<EXTRAORDINARY>                          0 
<CHANGES>                                0 
<NET-INCOME>                             1,820,517 
<EPS-PRIMARY>                            0.18 
<EPS-DILUTED>                            0.18 
         
 

</TABLE>
</TEXT> 
</DOCUMENT>
</IMS-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
